PortfoliosLab logoPortfoliosLab logo
TMO vs. JPM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TMO vs. JPM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Thermo Fisher Scientific Inc. (TMO) and JPMorgan Chase & Co. (JPM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMO achieves a -18.92% return, which is significantly lower than JPM's 0.50% return. Over the past 10 years, TMO has underperformed JPM with an annualized return of 12.54%, while JPM has yielded a comparatively higher 21.02% annualized return.


TMO

1D
-1.33%
1M
7.07%
YTD
-18.92%
6M
-17.84%
1Y
16.84%
3Y*
-3.43%
5Y*
0.45%
10Y*
12.54%

JPM

1D
2.31%
1M
7.69%
YTD
0.50%
6M
1.66%
1Y
23.40%
3Y*
34.22%
5Y*
17.82%
10Y*
21.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMO vs. JPM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TMO
Thermo Fisher Scientific Inc.
-18.92%11.78%-1.72%-3.36%-17.29%43.54%43.72%45.55%18.21%35.03%
JPM
JPMorgan Chase & Co.
0.50%37.27%44.29%30.63%-12.64%27.75%-5.53%47.26%-6.62%26.76%

Correlation

The correlation between TMO and JPM is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.32

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Sep 1, 1987

0.32

Fundamentals

Market Cap

TMO:

$175.06B

JPM:

$896.00B

EPS

TMO:

$18.22

JPM:

$21.08

PE Ratio

TMO:

25.76

JPM:

15.21

PS Ratio

TMO:

3.91

JPM:

3.14

PB Ratio

TMO:

3.37

JPM:

2.60

Total Revenue (TTM)

TMO:

$45.20B

JPM:

$285.09B

Gross Profit (TTM)

TMO:

$17.81B

JPM:

$173.52B

EBITDA (TTM)

TMO:

$11.16B

JPM:

$81.46B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMO vs. JPM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMO
TMO Risk / Return Rank: 5454
Overall Rank
TMO Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
TMO Sortino Ratio Rank: 5353
Sortino Ratio Rank
TMO Omega Ratio Rank: 5151
Omega Ratio Rank
TMO Calmar Ratio Rank: 5353
Calmar Ratio Rank
TMO Martin Ratio Rank: 5353
Martin Ratio Rank

JPM
JPM Risk / Return Rank: 6969
Overall Rank
JPM Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
JPM Sortino Ratio Rank: 6666
Sortino Ratio Rank
JPM Omega Ratio Rank: 6666
Omega Ratio Rank
JPM Calmar Ratio Rank: 7070
Calmar Ratio Rank
JPM Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMO vs. JPM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TMOJPMDifference
Sharpe ratioReturn per unit of total volatility

-0.58

Sortino ratioReturn per unit of downside risk

-0.56

Omega ratioGain probability vs. loss probability

1.10

1.18

-0.08

Calmar ratioReturn relative to maximum drawdown

0.43

1.42

-0.99

Martin ratioReturn relative to average drawdown

0.93

3.36

-2.42

TMO vs. JPM - Sharpe Ratio Comparison

The current TMO Sharpe Ratio is 0.43, which is lower than the JPM Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of TMO and JPM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TMO vs. JPM - Drawdown Comparison

The maximum TMO drawdown since its inception was -71.16%, smaller than the maximum JPM drawdown of -76.16%. Use the drawdown chart below to compare losses from any high point for TMO and JPM.


Loading charts...

Drawdown Indicators


TMOJPMDifference

Max Drawdown

Largest peak-to-trough decline

-71.16%

-76.16%

+5.00%

Max Drawdown (1Y)

Largest decline over 1 year

-31.38%

-15.47%

-15.91%

Max Drawdown (3Y)

Largest decline over 3 years

-37.28%

-24.42%

-12.86%

Max Drawdown (5Y)

Largest decline over 5 years

-40.95%

-38.77%

-2.18%

Max Drawdown (10Y)

Largest decline over 10 years

-40.95%

-43.63%

+2.68%

Current Drawdown

Current decline from peak

-28.80%

-3.66%

-25.14%

Average Drawdown

Average peak-to-trough decline

-18.11%

-17.62%

-0.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.43%

6.54%

+7.89%

Volatility

TMO vs. JPM - Volatility Comparison

Thermo Fisher Scientific Inc. (TMO) has a higher volatility of 10.57% compared to JPMorgan Chase & Co. (JPM) at 6.35%. This indicates that TMO's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TMOJPMDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.57%

6.35%

+4.22%

Volatility (6M)

Calculated over the trailing 6-month period

22.27%

16.67%

+5.60%

Volatility (1Y)

Calculated over the trailing 1-year period

31.48%

21.76%

+9.72%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.20%

24.46%

+2.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.38%

27.39%

-1.01%

Dividends

TMO vs. JPM - Dividend Comparison

TMO's dividend yield for the trailing twelve months is around 0.37%, less than JPM's 1.84% yield.


PositionTTM20252024202320222021202020192018201720162015
JPM
JPMorgan Chase & Co.
1.84%1.72%1.92%2.38%2.98%2.34%2.83%2.37%2.54%1.91%2.13%2.54%
TMO
Thermo Fisher Scientific Inc.
0.28%0.30%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%

Financials

TMO vs. JPM - Financials Comparison

This section allows you to compare key financial metrics between Thermo Fisher Scientific Inc. and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B20.00B30.00B40.00B50.00B60.00B70.00B20222023202420252026
11.01B
73.66B
(TMO) Total Revenue
(JPM) Total Revenue
Values in USD except per share items

TMO vs. JPM - Profitability Comparison

The chart below illustrates the profitability comparison between Thermo Fisher Scientific Inc. and JPMorgan Chase & Co. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
40.7%
64.3%
Portfolio components
TMO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported a gross profit of 4.48B and revenue of 11.01B. Therefore, the gross margin over that period was 40.7%.

JPM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a gross profit of 47.33B and revenue of 73.66B. Therefore, the gross margin over that period was 64.3%.

TMO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported an operating income of 1.86B and revenue of 11.01B, resulting in an operating margin of 16.9%.

JPM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported an operating income of 20.48B and revenue of 73.66B, resulting in an operating margin of 27.8%.

TMO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported a net income of 1.65B and revenue of 11.01B, resulting in a net margin of 15.0%.

JPM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, JPMorgan Chase & Co. reported a net income of 16.49B and revenue of 73.66B, resulting in a net margin of 22.4%.


Frequently Asked Questions


TMO and JPM have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TMO has higher volatility (10.57%) compared to JPM (6.35%). In terms of maximum drawdown, TMO dropped -71.16% vs JPM's -76.16%.

JPM currently has the higher Sharpe Ratio (1.01 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TMO and JPM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer